Blog: Supreme Court's DNA Decision Raises New Questions
Last week’s Supreme Court ruling threatens Myriad’s patent on breast cancer causing genes. But fuzzy interpretations about what types of DNA are patentable means the battle is far from over.
Last week’s Supreme Court ruling threatens Myriad’s patent on breast cancer causing genes. But fuzzy interpretations about what types of DNA are patentable means the battle is far from over.